The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Novel HIV-1 Integrase Inhibitors Derived from Quinolone Antibiotics
Abstract
The viral enzyme integrase is essential for the replication of human immunodeficiency virus type 1 (HIV-1) and represents a remaining target for antiretroviral drugs. Here, we describe the modification of a quinolone antibiotic to produce the novel integrase inhibitor JTK-303 (GS 9137) that blocks strand transfer by the viral enzyme. It shares the core structure of quinolone antibiotics, exhibits an IC50 of 7.2 nM in the strand transfer assay, and shows an EC50 of 0.9 nM in an acute HIV-1 infection assay.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the last 14 years, four more INSTIs were approved for treatment of HIV infection: elvitegravir, dolutegravir, bictegravir and cabotegravir147–150.”
From Structure and function of retroviral integrase (2022) · cites this paper as [147]
Citations
Cites
Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds
Pauwels, R., Balzarini, J., Baba, M., Snoeck, R., Schols, D., Herdewijn, P., Desmyter, J., & De Clercq, E. (1988) · Journal of Virological Methods · doi:10.1016/0166-0934(88)90134-6 · Cited by 1,642
Inhibitors of Strand Transfer That Prevent Integration and Inhibit HIV-1 Replication in Cells
Hazuda, D. J., Felock, P., Witmer, M., Wolfe, A., Stillmock, K., Grobler, J. A., Espeseth, A., Gabryelski, L., Schleif, W., Blau, C., et al. (2000) · Science · doi:10.1126/science.287.5453.646 · Cited by 1,131
Integrase inhibitors to treat HIV/Aids
Pommier, Y., Johnson, A. A., & Marchand, C. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1660 · Cited by 688
Goldgur, Y., Craigie, R., Cohen, G. H., Fujiwara, T., Yoshinaga, T., Fujishita, T., Sugimoto, H., Endo, T., Murai, H., & Davies, D. R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.23.13040 · Cited by 496
Acquired Dendritic Channelopathy in Temporal Lobe Epilepsy
Bernard, C., Anderson, A., Becker, A., Poolos, N. P., Beck, H., & Johnston, D. (2004) · Science · doi:10.1126/science.1097065 · Cited by 449
Richman, D. D. (2001) · Nature · doi:10.1038/35073673 · Cited by 419
Grobler, J. A., Stillmock, K., Hu, B., Witmer, M., Felock, P., Espeseth, A. S., Wolfe, A., Egbertson, M., Bourgeois, M., Melamed, J., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092056199 · Cited by 399
A Tale of Two Futures: HIV and Antiretroviral Therapy in San Francisco
Blower, S. M., Gershengorn, H. B., & Grant, R. M. (2000) · Science · doi:10.1126/science.287.5453.650 · Cited by 390
Hazuda, D. J., Anthony, N. J., Gomez, R. P., Jolly, S. M., Wai, J. S., Zhuang, L., Fisher, T. E., Embrey, M., Guare, J. P., Egbertson, M. S., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402357101 · Cited by 333
The Synthesis of Certain Substituted Quinolines and 5,6-Benzoquinolines
Gould, R. G., & Jacobs, W. A. (1939) · Journal of the American Chemical Society · doi:10.1021/ja01265a088 · Cited by 307
Research works printed but not linked: 4
- Barreca M. L., 2005, J. Med. Chem., 48, 7088
- Zhuang L., 2003, J. Med. Chem., 46, 456
- Anthony N. J., 2002, Aza- and polyaza-naphthalenyl carboxamides useful as HIV integrase inhibitors. PCT Int. Appl. WO02/30930 A2
- Cecchetti V., 1996, J. Med. Chem., 39, 445
Cited by
Items 201–300 of 358
Discovery of novel integrase-LEDGF/p75 allosteric inhibitors based on a benzene scaffold
Sugiyama, S., Iwaki, T., Tamura, Y., Tomita, K., Matsuoka, E., Arita, S., Seki, T., Yoshinaga, T., & Kawasuji, T. (2020) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2020.115643 · Cited by 12
The Integrase: An Overview of a Key Player Enzyme in the Antiviral Scenario
Renzi, G., Carta, F., & Supuran, C. T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512187 · Cited by 12
A mini-review on integrase inhibitors: The cornerstone of next-generation HIV treatment
Shalbi, F., & Ali, A. R. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116900 · Cited by 11
Structural Insights on Retroviral DNA Integration: Learning from Foamy Viruses
Lee, G.-E., Mauro, E., Parissi, V., Shin, C., & Lesbats, P. (2019) · Viruses · doi:10.3390/v11090770 · Cited by 11
Design and Synthesis of Novel Imidazopyridine Analogues and Evaluation as H+/K+-ATPase Antagonist
Sonawane, R. S., Shirsat, M. K., Patil, S. R., Hundiwale, J. C., & atil, A. V. P. (2020) · Asian Journal of Chemistry · doi:10.14233/ajchem.2020.22697 · Cited by 11
Discovery of 4-oxoquinolines, a new chemical class of anti-HIV-1 compounds
Shiroishi-Wakatsuki, T., Maejima-Kitagawa, M., Hamano, A., Murata, D., Sukegawa, S., Matsuoka, K., Ode, H., Hachiya, A., Imahashi, M., Yokomaku, Y., et al. (2018) · Antiviral Research · doi:10.1016/j.antiviral.2018.12.012 · Cited by 11
The crosstalk between antiretrovirals pharmacology and HIV drug resistance
Giacomelli, A., Pezzati, L., & Rusconi, S. (2020) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2020.1782737 · Cited by 11
Chi, G., Nair, V., Семенова, Е. А., & Pommier, Y. G. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.12.009 · Cited by 11
He, Q., Zhang, X., Wu, H.-Q., Gu, S., Ma, X.-D., Yang, L., Zheng, Y., & Chen, F. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.07.037 · Cited by 11
Inhibitors of HIV-1 Entry and Integration: Recent Developments and Impact on Treatment
Sharma, A. K., George, V., Valiathan, R., Pilakka‐Kanthikeel, S., & Pallikkuth, S. (2013) · Recent Patents on Inflammation & Allergy Drug Discovery · doi:10.2174/1872213x11307020006 · Cited by 12
Luo, Z. G., Zeng, C. C., Yang, L. F., He, H. Q., Wang, C. X., & Hu, L. (2009) · Chinese Chemical Letters · doi:10.1016/j.cclet.2009.03.014 · Cited by 10
Integrase inhibitors: current protagonists in antiretroviral therapy
Loaiza, J. D., Chvatal‐Medina, M., Hernández, J. C., & Rugeles, M. T. (2023) · Immunotherapy · doi:10.2217/imt-2023-0011 · Cited by 11
Wicke, L., Engels, J. W., Gambari, R., & Saab, A. M. (2013) · Archiv der Pharmazie · doi:10.1002/ardp.201300232 · Cited by 10
Soliman, S. M., Kassem, T. S., Badr, A. M. A., Youssef, M. A. M. A., & Assem, R. (2014) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2014.05.077 · Cited by 10
Unprocessed Viral DNA Could Be the Primary Target of the HIV-1 Integrase Inhibitor Raltegravir
Ammar, F. F., Abdel‐Azeim, S., Zargarian, L., Hobaika, Z., Maroun, R. G., & Fermandjian, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040223 · Cited by 11
Weber, J., Rose, J. D., Vazquez, A. C., Winner, D., Margot, N., McColl, D. J., Miller, M. D., & Quiñones‐Mateu, M. E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065631 · Cited by 10
Leyva‐Ramos, S., de Loera, D. A., & Cardoso‐Ortiz, J. (2017) · Chemotherapy · doi:10.1159/000456533 · Cited by 11
de Campos, L. J., & de Melo, E. B. (2017) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2017.03.103 · Cited by 9
Ghosh, P., & Das, S. (2018) · ChemistrySelect · doi:10.1002/slct.201801756 · Cited by 9
HIV integrase inhibitors that inhibit strand transfer interact with RAG1 and hamper its activities
Nilavar, N. M., & Raghavan, S. C. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107515 · Cited by 9
Critical appraisal of elvitegravir in the treatment of HIV-1/AIDS
Pandey, K. K. (2014) · HIV/AIDS - Research and Palliative Care · doi:10.2147/hiv.s39178 · Cited by 9
Safakish, M., Hajimahdi, Z., Vahabpour, R., Zabihollahi, R., & Zarghi, A. (2019) · Medicinal Chemistry · doi:10.2174/1573406415666190826161123 · Cited by 8
Ribonucleic Acid Viruses: Antivirals for Human Immunodeficiency Virus
Lyle, T. A. (2007) · Elsevier eBooks · doi:10.1016/b0-08-045044-x/00213-3 · Cited by 9
HIV-1 Integrase Drug Discovery Comes of Age
Demeulemeester, J., Maeyer, M. D., & Debyser, Z. (2013) · Topics in medicinal chemistry · doi:10.1007/7355_2013_33 · Cited by 9
Vandurm, P., Cauvin, C., Guiguen, A., Georges, B., Van, K. L., Martinelli, V., Cardona, C., Mbemba, G., Mouscadet, J. F., Hevesi, L., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.06.044 · Cited by 8
Prospective Strategies for Targeting HIV-1 Integrase Function
Luo, Y., & Muesing, M. A. (2010) · Future Medicinal Chemistry · doi:10.4155/fmc.10.205 · Cited by 9
Shantharjun, B., Rajeswari, R., Vani, D., Unnava, R., Sridhar, B., & Reddy, K. R. (2019) · Asian Journal of Organic Chemistry · doi:10.1002/ajoc.201900588 · Cited by 7
Reporter gene expression from LTR-circles as tool to identify HIV-1 integrase inhibitors
Loock, M. V., Hombrouck, A., Jacobs, T., Winters, B., Meersseman, G., Acker, K. V., Clayton, R., & Malcolm, B. A. (2012) · Journal of Virological Methods · doi:10.1016/j.jviromet.2012.11.016 · Cited by 6
Cyclic Hexapeptide Mimics of the LEDGF Integrase Recognition Loop in Complex with HIV‐1 Integrase
Northfield, S. E., Wielens, J., Headey, S. J., Williams‐Noonan, B. J., Mulcair, M. D., Scanlon, M. J., Parker, M. W., Thompson, P. E., & Chalmers, D. K. (2018) · ChemMedChem · doi:10.1002/cmdc.201800129 · Cited by 8
HCV versus HIV drug discovery: Déjà vu all over again?
Watkins, W. J., & Desai, M. C. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.02.070 · Cited by 9
Musat, M., Nițulescu, G. M., Surleac, M. D., Tsatsakis, A. M., Spandidos, D. A., & Margina, D. M. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10777 · Cited by 8
Siegel, L., & Gulick, R. M. (2007) · Current Infectious Disease Reports · doi:10.1007/s11908-007-0038-8 · Cited by 7
Novel antiretroviral agents in HIV therapy
Reed, C., & Daar, E. S. (2006) · Current Infectious Disease Reports · doi:10.1007/s11908-006-0024-6 · Cited by 7
Egbertson, M. S., Wai, J. S. M., Cameron, M. J., & Hoerrner, R. S. (2011) · Wiley eBooks · doi:10.1002/9780470929353.ch12 · Cited by 8
New designs for HIV-1 integrase inhibitors: a patent review (2018-present)
Taoda, Y., Sugiyama, S., & Seki, T. (2023) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2023.2178300 · Cited by 7
A novel high-throughput cellular screening assay for the discovery of HIV-1 integrase inhibitors
Loock, M. V., Meersseman, G., Acker, K. V., den Eynde, C. V., Jochmans, D., Schoubroeck, B. V., Dams, G., Heyndríckx, L., & Clayton, R. (2011) · Journal of Virological Methods · doi:10.1016/j.jviromet.2011.11.029 · Cited by 6
Xu, X. M., Luo, Z. G., He, K., & Zhang, M. Y. (2013) · Advanced materials research · doi:10.4028/www.scientific.net/amr.634-638.1116 · Cited by 6
Khoury, L. E., Piquemal, J., Fermandjian, S., Maroun, R. G., Gresh, N., & Hobaika, Z. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.05.001 · Cited by 8
Integration of human immunodeficiency virus as a target for antiretroviral therapy
Семенова, Е. А., Johnson, A. A., Marchand, C., & Pommier, Y. G. (2006) · Current Opinion in HIV and AIDS · doi:10.1097/01.coh.0000239850.14991.f9 · Cited by 8
Gupta, M., & Madan, A. K. (2012) · Archiv der Pharmazie · doi:10.1002/ardp.201100316 · Cited by 6
Gresh, N., Hage, K. E., Goldwaser, E., de Courcy, B., Chaudret, R., Pérahia, D., Narth, C., Lagardère, L., Lipparini, F., & Piquemal, J. (2015) · Challenges and advances in computational chemistry and physics · doi:10.1007/978-3-319-21626-3_1 · Cited by 7
Ghosh, P., Chhetri, G., Mandal, A., Mahato, M., & Das, S. (2023) · Asian Journal of Organic Chemistry · doi:10.1002/ajoc.202300286 · Cited by 5
Mollova-Sapundzhieva, Y., Angelov, P., Georgiev, D., & Yanev, P. (2023) · Beilstein Journal of Organic Chemistry · doi:10.3762/bjoc.19.132 · Cited by 6
Akiyama, T., Johns, B. A., Taoda, Y., Yoshida, H., Taishi, T., Kawasuji, T., Murai, H., Yoshinaga, T., Sato, A., Seki, T., et al. (2024) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2024.129902 · Cited by 5
Du, W., Zuo, K., Sun, X., Liu, W., Yan, X. H., Liang, L., Wan, H., Chen, F., & Hu, J. (2017) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2017.10.002 · Cited by 5
Competitive Intelligence–based Lead Generation and Fast Follower Approaches
Jiang, Y. Y., Liu, Z., Holenz, J., & Yang, H. D. (2016) · Methods and principles in medicinal chemistry · doi:10.1002/9783527677047.ch08 · Cited by 5
Unveiling biosynthetic potential of an Arctic marine-derived strain Aspergillus sydowii MNP-2
Fu, Z., Gong, X., Hu, Z., Wei, B., & Zhang, H. (2024) · BMC Genomics · doi:10.1186/s12864-024-10501-0 · Cited by 4
Li, C., Zhang, W., Xu, Y., Su, Y., Gao, T., Ye, J., Song, L., & Yu, D. (2025) · Organic Chemistry Frontiers · doi:10.1039/d5qo00491h · Cited by 4
Johns, B. A., Kawasuji, T., & Velthuisen, E. J. (2013) · Royal Society of Chemistry eBooks · doi:10.1039/9781849737814-00149 · Cited by 6
Recent Advances Towards Treatment of HIV: Synthesis and SAR Studies
Shrivastava, N., Husain, A., Rashid, M., Alsabeelah, N. F., Karim, S., & Siddiqui, N. A. (2019) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557519666190312170158 · Cited by 4
Rao, M. S., & Hussain, S. (2021) · Tetrahedron Letters · doi:10.1016/j.tetlet.2021.153187 · Cited by 4
Yao, W., Xie, X., Liu, J., & Xie, J. (2022) · Organic & Biomolecular Chemistry · doi:10.1039/d2ob00020b · Cited by 4
Taoda, Y., Akiyama, T., Tomita, K., Fujiwara-Kitamura, M., Tamura, Y., Kawasuji, T., Matsuoka, E., Akihisa, E., Seki, T., & Yoshinaga, T. (2022) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2022.128664 · Cited by 4
Development of Synthetic Approaches Towards HIV Integrase Strand Transfer Inhibitors (INSTIs)
Sawant, A. A., Jadav, S. S., Nayani, K., & Mainkar, P. S. (2022) · ChemistrySelect · doi:10.1002/slct.202201915 · Cited by 4
A concise synthesis of HIV integrase inhibitors bearing the dipyridone acid motif
Platts, M. Y., Barber, C., Chiva, J., Eastwood, R. L., Fenwick, D. R., Paradowski, K. A., & Blakemore, D. C. (2010) · Tetrahedron Letters · doi:10.1016/j.tetlet.2010.11.112 · Cited by 4
Structural and Functional Insights into Foamy Viral Integrase
Hossain, M. A., Ali, M. K., & Shin, C. (2013) · Viruses · doi:10.3390/v5071850 · Cited by 6
Strategies for Identification of HIV-1 Integrase Inhibitors
Ramcharan, J., & Skalka, A. M. (2006) · Future Virology · doi:10.2217/17460794.1.6.717 · Cited by 4
Thermodynamics of complexes formation by ITC in methanol/water=9/1 (v/v) solution: A case study
Fisicaro, E., Compari, C., Bacciottini, F., Contardi, L., Carcelli, M., Rispoli, G., & Rogolino, D. (2014) · Thermochimica Acta · doi:10.1016/j.tca.2014.04.003 · Cited by 3
In vitro selection of G-rich RNA aptamers that target HIV-1 integrase
Liu, Y., Zhang, Y., Ye, G., Yang, Z., Zhang, L., & Zhang, L. (2008) · Science China Chemistry · doi:10.1007/s11426-008-0056-x · Cited by 3
Crosby, D. C., Lei, X., Gibbs, C. G., Reinecke, M. G., & Robinson, W. E. (2015) · Natural Product Communications · doi:10.1177/1934578x1501000129 · Cited by 3
Dembélé, O., Montoir, D., Yvorra, T., Sérillon, D., Tonnerre, A., Duflos, M., Robert, J.-M., & Bazin, M. (2018) · Tetrahedron Letters · doi:10.1016/j.tetlet.2018.08.013 · Cited by 3
Deo, K. D., Singhvi, I. J., Patil, S., & Patil, A. V. (2019) · Asian Journal of Chemistry · doi:10.14233/ajchem.2019.22045 · Cited by 3
Nair, V., Uchil, V. R., Chi, G., Dams, I., Cox, A. G., & Seo, B. (2007) · Nucleosides Nucleotides & Nucleic Acids · doi:10.1080/15257770701490563 · Cited by 3
Pharmacokinetics and dose-range finding toxicity of a novel anti-HIV active integrase inhibitor
Nair, V., Okello, M. O., Mishra, S., Mirsalis, J. C., O’Loughlin, K. G., & Zhong, Y. (2014) · Antiviral Research · doi:10.1016/j.antiviral.2014.05.001 · Cited by 3
Arellano, I., Sharma, P., Rubio‐Pérez, L., Cabrera, A., Rosas, N., & Toscano, R. A. (2011) · Journal of Organometallic Chemistry · doi:10.1016/j.jorganchem.2011.11.010 · Cited by 3
Reddy, S. M., Rao, D. S., Sudhamani, H., Kumari, P. G., & Raju, C. N. (2015) · Phosphorus, sulfur, and silicon and the related elements · doi:10.1080/10426507.2015.1054484 · Cited by 3
Amézquita‐Valencia, M., & Alper, H. (2016) · Chemistry - A European Journal · doi:10.1002/chem.201603941 · Cited by 3
Role of Metals in HIV‐1 Integrase Inhibitor Design
Sechi, M., Carcelli, M., Rogolino, D., & Neamati, N. (2011) · Wiley eBooks · doi:10.1002/9781118015377.ch20 · Cited by 6
Liao, C., & Nicklaus, M. C. (2011) · Wiley eBooks · doi:10.1002/9781118015377.ch28 · Cited by 3
Péret, V. A. C., Reis, A. C. C., Agostini, L. D. C., Pereira, I. O. A., da Silva, G. N., Carvalho, D. T., Lavorato, S. N., Braga, S. F. P., Brandão, G. C., & de Souza, T. B. (2025) · ChemMedChem · doi:10.1002/cmdc.202500323 · Cited by 2
Zhao, X. Z., Li, M., Smith, S. J., Karbasi, A. B., Choudhuri, I., Jing, T., Lyumkis, D., Craigie, R., & Burke, T. R. (2025) · NAR Molecular Medicine · doi:10.1093/narmme/ugaf039 · Cited by 3
Sakkhachornphop, S., Thongkum, W., & Tayapiwatana, C. (2015) · BioMed Research International · doi:10.1155/2015/853891 · Cited by 2
Ring expansion of 3-hydroxyoxindoles to 4-quinolones via palladium-catalyzed C–C(acyl) bond cleavage
Huang, Z.-C., Ruan, Z.-L., Xu, H., & Dai, H. (2024) · Chemical Communications · doi:10.1039/d4cc05369a · Cited by 2
Status Presens of Antiviral Drugs And Strategies: Part I: DNA Viruses and Retroviruses
Clercq, E. D. (2007) · Advances in antiviral drug design · doi:10.1016/s1075-8593(06)05001-5 · Cited by 4
HIV-1 Integrase Strand Transfer Inhibitors
Johns, B. A. (2010) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(10)45016-2 · Cited by 2
Chen, X., Gong, J.-W., Zhang, X., Liu, X.-L., Liu, W., & Wang, Y. (2017) · Tetrahedron · doi:10.1016/j.tet.2017.12.003 · Cited by 2
Peptidomimetics That Mimic the Tertiary Structures of Peptides
Tamamura, H., Kobayakawa, T., & Ohashi, N. (2018) · SpringerBriefs in pharmaceutical science & drug development · doi:10.1007/978-981-10-7691-6_5 · Cited by 2
Base Promoted Synthesis of 4‐Quinolones Fused with Medium‐Sized Rings
Wang, M., Ma, J., Wang, J., Lu, W., & Pan, B. (2023) · European Journal of Organic Chemistry · doi:10.1002/ejoc.202300519 · Cited by 2
Elvitegravir, A New HIV‐1 Integrase Inhibitor for Antiretroviral Therapy
Shinkai, H. (2015) · Wiley eBooks · doi:10.1002/9783527678433.ch6 · Cited by 2
Self-citationElvitegravir: A Novel Monoketo Acid HIV‐1 Integrase Strand Transfer Inhibitor
Shinkai, H., Sato, M., & Matsuzaki, Y. (2011) · Wiley eBooks · doi:10.1002/9780470929353.ch14 · Cited by 2
Self-citationElvitegravir: An Emerging HIV Integrase Inhibitor
Shimura, K., & Kodama, E. N. (2008) · Future HIV Therapy · doi:10.2217/17469600.2.5.411 · Cited by 2
Self-citationFrom AZT to treatment as prevention. The evolution of antiretroviral therapy for HIV/AIDS
Duarte, C. A., Paneque, T., Ramírez, A., Casillas, D., & Fernández‐Ortega, C. (2015) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 1
Sonawane, R. S., Patil, K. D., & Patil, A. V. (2020) · Asian Journal of Chemistry · doi:10.14233/ajchem.2020.22433 · Cited by 1
Imani, A., Soleymani, S., Vahabpour, R., Hajimahdi, Z., & Zarghi, A. (2021) · Medicinal Chemistry · doi:10.2174/1573406417666210125141639 · Cited by 2
Retroviral Integrase Structure and DNA Recombination Mechanism
Engelman, A., & Cherepanov, P. (2015) · ASM Press eBooks · doi:10.1128/9781555819217.ch44 · Cited by 2
Peptidomimetics That Mimic the Secondary Structures of Peptides
Tamamura, H., Kobayakawa, T., & Ohashi, N. (2018) · SpringerBriefs in pharmaceutical science & drug development · doi:10.1007/978-981-10-7691-6_4 · Cited by 1
Gurunani, G. A., Agrawal, K. M., Walde, S., & Ittadwar, A. (2022) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2022.00731 · Cited by 1
Alaoui, K., Kaya, S., Salim, R., Kamal, A., Moussaoui, A., Habsaoui, A., Touhami, M. E., & Kacimi, Y. E. (2023) · Advances in chemical and materials engineering book series · doi:10.4018/978-1-6684-7689-5.ch004 · Cited by 1
Mirambeau, G. (2008) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/s0213-005x(08)76567-4 · Cited by 1
Nakamura, T., Campbell, J. R., Moore, A. R., Otsu, S., Aikawa, H., Tamamura, H., & Mitsuya, H. (2016) · Journal of Virological Methods · doi:10.1016/j.jviromet.2016.07.023 · Cited by 1
Computer‐Aided Techniques in Design of HIV‐1 Integrase Inhibitors
Serrao, E., Gundla, R., Deng, J. N., Odde, S., & Neamati, N. (2011) · Wiley eBooks · doi:10.1002/9781118015377.ch26 · Cited by 1
3D enantioselective descriptors for ligand-based computer-aided drug design
Sliwoski, G. R. (2012) · Cited by 1
Biochemical, Structural, And Drug Design Studies Of Multi-Drug Resistant Hiv-1 Therapeutic Targets
Dewdney, T. G. (2013) · Human Biology · Cited by 1
Herman, B. D. (2012) · D-Scholarship@Pitt (University of Pittsburgh)
Raltegravir (Isentress): The First‐in‐Class HIV‐1 Integrase Inhibitor
Hunt, J. A. (2010) · Wiley eBooks · doi:10.1002/9780470768594.ch1
Process Development of HIV Integrase Inhibitor S‐1360
Konoike, T., & Shimizu, S. (2010) · doi:10.1002/9783527633678.ch11
"Synthesis and Computational Studies on Hiv-1 Integrase Inhibitors"
Sharma, H. (2011) · doi:10.21007/etd.cghs.2011.0285 · Cited by 1
Elvitegravir: Novel Quinolone HIV‐1 Integrase Strand Transfer Inhibitor
Shinkai, H., Sato, M., & Matsuzaki, Y. (2011) · Wiley eBooks · doi:10.1002/9781118015377.ch15
Self-citationSlow‐Onset Kinetics of HIV Integrase Inhibitors and Proposed Molecular Model
Garvey, E. P., & Schwartz, B. J. (2011) · Wiley eBooks · doi:10.1002/9781118015377.ch17
Christ, F. (2010) · HIV Therapy · doi:10.2217/hiv.10.21
Metadata
- Authors
- Sato, M., Motomura, T., Aramaki, H., Matsuda, T., Yamashita, M., Ito, Y., Kawakami, H., Matsuzaki, Y., Watanabe, W., Yamataka, K., Ikeda, S., Kodama, E., Matsuoka, M., & Shinkai, H.
- Affiliations
- Kyoto University (JP)
- Central Pharmaceutical Research Institute, JT Inc., 1-1 Murasaki-cho, Takatsuki, Osaka, 569-1125, Japan, and Institute for Virus Research, Kyoto University, 53 Shogoin Kawaramachi, Sakyo-ku, Kyoto, 606-8507, Japan
- Corresponding author
- Shinkai, Hisashi
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2006-02-15
- Volume
- 49
- Issue
- 5
- Pages
- 1506-1508
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2025444624
- Cited by
- 328
- References
- 17
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 8 · 2023: 11 · 2022: 11 · 2021: 12 · 2020: 15 · 2019: 22 · 2018: 15 · 2017: 15 · 2016: 10 · 2015: 14 · 2014: 16 · 2013: 22 · 2012: 21
- FWCI
- 15.08
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Medicinal Chemistry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Keywords
- HIV-1 integrase inhibitors, quinolones, strand transfer inhibition, antiretroviral drug design, HIV-1 replication, acute HIV-1 infection
- MeSH terms
- Anti-Bacterial Agents, Cell Line, DNA, Viral, Humans, Structure-Activity Relationship, Quinolones, HIV-1, HIV Integrase, HIV Integrase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.